Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-24-000150
Filing Date
2024-02-13
Accepted
2024-02-13 18:43:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 oric13ga2024.htm SC 13G/A 40770
  Complete submission text file 0000935836-24-000150.txt   42397
Mailing Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017
Business Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017 2127166576
ALKEON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001230239 (see all company filings)

EIN.: 134200093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91490 | Film No.: 24630849
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)